I juni 2002 ansøgte Allergan Pharmaceuticals (Irland) Ltd, indehaveren af markedsføringstilladelsen, om en ny indikation under proceduren for gensidig anerkendelse af markedsføringstilladelserne for Botox vedrørende behandling af aksillær hyperhidrosis.
In June 2002, the Marketing Authorisation Holder, Allergan Pharmaceuticals (Ireland) Ltd applied for a new indication through Mutual Recognition Procedure (MRP), for Botox for the treatment of axillary hyperhidrosis.